Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 335 of the 339 references it cites were found in a registry or an index.

The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy

Open access
Puris, Elena, Fricker, Gert, Gynther, Mikko · 2023 · Pharmaceutics

Abstract

Transporter-mediated drug resistance is a major obstacle in anticancer drug delivery and a key reason for cancer drug therapy failure. Membrane solute carrier (SLC) transporters play a crucial role in the cellular uptake of drugs. The expression and function of the SLC transporters can be down-regulated in cancer cells, which limits the uptake of drugs into the tumor cells, resulting in the inefficiency of the drug therapy. In this review, we summarize the current understanding of low-SLC-transporter-expression-mediated drug resistance in different types of cancers. Recent advances in SLC-transporter-targeting strategies include the development of transporter-utilizing prodrugs and nanocarriers and the modulation of SLC transporter expression in cancer cells. These strategies will play an important role in the future development of anticancer drug therapies by enabling the efficient delivery of drugs into cancer cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/pharmaceutics15020364

Cites

335 of 335 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The main mechanisms of anticancer drug resistance.
Figure 1 The main mechanisms of anticancer drug resistance.CC BY · PubMed Central
Figure 2 Schematic representation of the consequences of transporter-mediated resistance to anticancer drugs in cancer and normal cells.
Figure 2 Schematic representation of the consequences of transporter-mediated resistance to anticancer drugs in cancer and normal cells.CC BY · PubMed Central
Figure 3 Schematic illustration of the molecular mechanisms which can be targeted to increase SLC drug transporter expression on cell plasma membrane. Nucleus receptor (1), DNA de-methylation (2) and histone de-acetylation (3) mediated increase in transporter expression. Ubiquitination inhibition mediated reduction of transporter recycling from the plasma membrane (4). Inhibition of Protein kinases C (PKCs) mediated internalization of transporters from plasma membrane (5).
Figure 3 Schematic illustration of the molecular mechanisms which can be targeted to increase SLC drug transporter expression on cell plasma membrane. Nucleus receptor (1), DNA de-methylation (2) and histone de-acetylation (3) mediated increase in transporter expression. Ubiquitination inhibition mediated reduction of transporter recycling from the plasma membrane (4). Inhibition of Protein kinases C (PKCs) mediated internalization of transporters from plasma membrane (5).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 339 references

Cited by

See all 65

Metadata

Authors
Puris, E., Fricker, G., & Gynther, M.
Affiliations
Heidelberg University (DE)
Corresponding author
Gynther, Mikko
Venue
Pharmaceutics
Publisher
MDPI AG
Published
2023-01-21
Volume
15
Issue
2
Pages
364
ISSN
1999-4923 (ISSN-L)
OpenAlex
W4317733597
Cited by
58
References
339
Citations by year
2026: 10 · 2025: 26 · 2024: 19 · 2023: 3
FWCI
1.88
Type
journal article
Language
en
Open access
Locations
  • Pharmaceutics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
Keywords
solute carrier transporters, anticancer drug delivery, drug resistance, cancer cells, drug uptake, nanocarriers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy. https://app.cochat.ai/papers/10.3390/pharmaceutics15020364
The paper
Puris, E., Fricker, G., & Gynther, M. (2023). The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy. Pharmaceutics. https://doi.org/10.3390/pharmaceutics15020364

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.